Table 1 Patients characteristics for propensity score matched pairs (n = 50). Data is given as median and 95% confidence interval.

From: Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis

 

PPI

No PPI

p-value

Age (years)

58 (56–62)

55 (53–60)

0.117

Sex (female/male)

10/40 (20%/80%)

13/37 (26%/74%)

0.635

Child-Pugh score

6 (5–6)

6 (5–7)

0.895

MELD score

11 (10–13)

11.5 (10–13)

0.669

Antibiotic use

2 (4%)

0 (0%)

0.495

Metformin

8 (16%)

5 (10%)

0.554

Lactulose

8 (16%)

2 (4%)

0.091

  1. PPI: proton pump inhibitor.
Back to article page